• OPEN AN ACCOUNT
Indian Indices
Nifty
25,212.05 16.25
(0.06%)
Sensex
82,390.20 -244.28
( -0.30%)
Bank Nifty
57,168.95 162.30
( 0.28%)
Nifty IT
37,660.75 236.15
( 0.63%)
Global Indices
Nasdaq
44,266.94 222.64
(0.51%)
Dow Jones
6,284.11 19.35
(0.31%)
Hang Seng
39,856.94 193.54
(0.49%)
Nikkei 225
8,926.55 -11.77
(-0.13%)
Forex
USD-INR
85.90 0.01
(0.01%)
EUR-INR
100.04 -0.25
(-0.25%)
GBP-INR
115.25 -0.37
(-0.32%)
JPY-INR
0.58 0.00
(-0.51%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
82.11
181301.77
EPS(TTM)
Face Value()
Div & Yield %
83.18
2
0.44
 

greencrest financial services ltd
Arihant Superstructures Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday June 14 2025.
Jun 14,2025
The Board of Directors of Arihant Superstructures Limited (Company) at its Meeting held today i.e. June 14 2025 has allotted 2090000 equity shares of face value of Rs.10/- each fully paid up to Warrant holders consequent to the Warrant holder having exercised their right for conversion of Share Warrants (Warrants) into equity shares. The allotment has been made for cash upon the receipt of the remaining exercise price of Rs. 135.053/- per Share Warrant (being an amount equivalent to the 75% of the warrant exercise price of Rs. 180.071/- per warrant) aggregating to Rs. 28.23 Crore. These equity shares allotted on conversion of the warrants shall rank pari-passu in all respects with the existing equity shares of the Company including dividend if any.